SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-202089
Filing Date
2021-06-28
Accepted
2021-06-28 16:44:59
Documents
16
Period of Report
2021-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d175431d8k.htm   iXBRL 8-K 32813
2 EX-5.1 d175431dex51.htm EX-5.1 14393
3 EX-10.1 d175431dex101.htm EX-10.1 215572
7 GRAPHIC g175431g0625120955754.jpg GRAPHIC 1812
8 GRAPHIC g175431sp06.jpg GRAPHIC 2926
  Complete submission text file 0001193125-21-202089.txt   455506

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zsan-20210628.xsd EX-101.SCH 2903
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20210628_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20210628_pre.xml EX-101.PRE 10960
9 EXTRACTED XBRL INSTANCE DOCUMENT d175431d8k_htm.xml XML 3270
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211054086
SIC: 2834 Pharmaceutical Preparations